FDA Inspection 1170288 — Mercy Research IRB
The FDA completed an inspection of Mercy Research IRB on Apr 11, 2022 in Chesterfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 11, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chesterfield, MO (United States)
Additional Details
IRB